This webinar is not just another summary of the long-awaited decision by the Second Circuit in United States v. Caronia. Nor is it merely high-level positing about the future of off-label promotion prosecutions. This webinar will provide practical tips to address the real-world implications to companies from this significant decision. The impacts go beyond just the pharmaceutical marketing industry – the marketing of devices, dietary supplements, and tobacco products likely will be affected.
Hear from experts who evaluate and advise FDA-regulated industries about relevant business considerations that are impacted by Caronia